Glen Eagle Advisors’s Procter & Gamble PG Stock Holding History

Glen Eagle Advisors’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Buy	10,753 +70	+0.7%	+$10.2K	0.2%	84
2026 Q1	$1.54M	Sell	10,683 -544	-5%	-$82.5K	0.22%	76
2025 Q4	$1.61M	Sell	11,227 -2,361	-17%	-$348K	0.22%	82
2025 Q3	$2.09M	Sell	13,588 -694	-5%	-$108K	0.29%	64
2025 Q2	$2.28M	Sell	14,282 -476	-3%	-$77.7K	0.35%	57
2025 Q1	$2.52M	Sell	14,758 -327	-2%	-$54.8K	0.42%	45
2024 Q4	$2.53M	Buy	15,085 +180	+1%	+$30.7K	0.42%	51
2024 Q3	$2.58M	Sell	14,905 -273	-2%	-$46.3K	0.44%	49
2024 Q2	$2.5M	Sell	15,178 -1,182	-7%	-$193K	0.46%	49
2024 Q1	$2.65M	Sell	16,360 -360	-2%	-$56.5K	0.5%	44
2023 Q4	$2.45M	Sell	16,720 -1,081	-6%	-$160K	0.51%	45
2023 Q3	$2.6M	Buy	17,801 +253	+1%	+$38.6K	0.6%	38
2023 Q2	$2.66M	Buy	17,548 +1,462	+9%	+$220K	0.61%	37
2023 Q1	$2.39M	Sell	16,086 -3,706	-19%	-$530K	0.6%	40
2022 Q4	$3M	Sell	19,792 -1,602	-7%	-$225K	0.82%	32
2022 Q3	$2.7M	Sell	21,394 -3,716	-15%	-$528K	0.78%	31
2022 Q2	$3.61M	Buy	25,110 +3,488	+16%	+$524K	0.98%	26
2022 Q1	$3.3M	Buy	21,622 +815	+4%	+$128K	0.86%	28
2021 Q4	$3.4M	Buy	20,807 +1,432	+7%	+$213K	0.89%	26
2021 Q3	$2.71M	Buy	19,375 +2,521	+15%	+$357K	0.78%	29
2021 Q2	$2.27M	Buy	16,854 +1,043	+7%	+$141K	0.71%	34
2021 Q1	$2.15M	Buy	15,811 +1,018	+7%	+$133K	0.75%	32
2020 Q4	$2.06M	Sell	14,793 -729	-5%	-$102K	0.81%	30
2020 Q3	$2.16M	Buy	15,522 +523	+3%	+$69.4K	0.97%	23
2020 Q2	$1.79M	Buy	14,999 +4,230	+39%	+$493K	0.92%	24
2020 Q1	$1.18M	Buy	10,769 +701	+7%	+$84.1K	0.83%	30
2019 Q4	$1.26M	Buy	10,068 +4,598	+84%	+$563K	0.67%	37
2019 Q3	$680K	Buy	5,470 +35	+0.6%	+$4.14K	0.45%	56
2019 Q2	$596K	Buy	5,435 +14	+0.3%	+$1.49K	0.41%	58
2019 Q1	$564K	Buy	5,421 +60	+1%	+$5.84K	0.41%	56
2018 Q4	$493K	Sell	5,361 -22	-0.4%	-$1.97K	0.42%	59
2018 Q3	$448K	Sell	5,383 -49	-0.9%	-$4.01K	0.32%	74
2018 Q2	$424K	Sell	5,432 -2,583	-32%	-$194K	0.33%	71
2018 Q1	$635K	Buy	8,015 +1,163	+17%	+$97K	0.52%	50
2017 Q4	$630K	Buy	6,852 +918	+15%	+$82.6K	0.55%	47
2017 Q3	$540K	Sell	5,934 -2,266	-28%	-$206K	0.5%	49
2017 Q2	$728K	Buy	8,200 +1,066	+15%	+$94K	0.58%	38
2017 Q1	$643K	Buy	7,134 +105	+1%	+$9.31K	0.55%	44
2016 Q4	$591K	Buy	+7,029	New	+$599K	0.53%	46

Other funds holding PG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Glen Eagle Advisors's PG Position: Q2 2026 in Review

Glen Eagle Advisors increased its Procter & Gamble (PG) stake by 0.66% in Q2 2026, buying an estimated $10.2K and bringing the position to 10,753 shares worth $1.58M. The position accounts for 0.2% of the portfolio, ranked #84.

Glen Eagle Advisors first reported a position in PG in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.61M in Q2 2022. 4,020 funds tracked by Wall St. Rank hold PG as of Q2 2026.

Glen Eagle Advisors held 10,753 shares of Procter & Gamble worth $1.58M as of Q2 2026.
Glen Eagle Advisors bought 70 Procter & Gamble shares in Q2 2026, an estimated $10.2K.
Procter & Gamble made up 0.2% of Glen Eagle Advisors's portfolio in Q2 2026, its #84 holding.
Glen Eagle Advisors first reported a position in Procter & Gamble in Q4 2016 and has held it in 39 quarters since.
Glen Eagle Advisors's Procter & Gamble position peaked at $3.61M in Q2 2022.
4,020 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.